Veteran on heparin drip who goes into HIT - Nursing Case Study

Pathophysiology

• Primary mechanism: Heparin-induced thrombocytopenia (HIT) is an immune-mediated reaction where heparin binds to platelet factor 4 (PF4), forming a complex that triggers antibody production, leading to platelet activation and aggregation.

• Secondary mechanism: Activated platelets release procoagulant microparticles, resulting in a paradoxical state of thrombosis despite the low platelet count, causing increased risk of venous and arterial clots.

• Key complication: The formation of these clots can lead to severe outcomes such as deep vein thrombosis, pulmonary embolism, or stroke, necessitating immediate adjustment of anticoagulation therapy to mitigate these risks.

Patient Profile

Demographics:

62-year-old male, retired Army Sergeant

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Deep Vein Thrombosis

• Current medications: Metformin, Lisinopril, Heparin (IV drip)

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset of severe leg pain and swelling

• Key symptoms: Decreased urine output, skin rash, shortness of breath

• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 22 breaths/min, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the medical team assesses the situation, they note the critical signs pointing toward heparin-induced thrombocytopenia (HIT). The patient's platelet count, initially recorded at 230,000/µL prior to admission, has now drastically dropped to 70,000/µL. This significant reduction in platelet count, coupled with the sudden onset of severe leg pain, swelling, and a new rash, underscores the likely diagnosis of HIT. The rash, presenting as petechiae on the lower extremities, further supports the diagnosis and raises concern for potential thrombotic events. Given his history of deep vein thrombosis, the team is particularly vigilant for signs of new clot formation, which could lead to life-threatening complications such as pulmonary embolism.

With the patient experiencing decreased urine output, the team orders a comprehensive metabolic panel, which reveals an elevated creatinine level of 2.0 mg/dL, indicating potential acute kidney injury. This finding is concerning for renal involvement, likely secondary to microvascular thrombosis. In conjunction with an oxygen saturation persistently at 92% on room air and an increased respiratory rate, there is growing suspicion of a pulmonary embolism or other form of thrombotic insult affecting the lungs. The team considers a CT pulmonary angiogram to evaluate for pulmonary embolism, as well as an ultrasound of the affected leg to confirm deep vein thrombosis.

The immediate response involves discontinuing the heparin drip and initiating alternative anticoagulation therapy with a direct thrombin inhibitor, such as argatroban, to prevent further clot formation while managing the low platelet count. The nursing staff is instructed to closely monitor the patient’s vital signs, urine output, and oxygenation status while preparing for possible escalation of care, including the need for intensive monitoring or transfer to a higher acuity setting. As they implement the new treatment plan, the team remains vigilant for any signs of worsening respiratory distress or hemodynamic instability, which would necessitate rapid intervention.

Section 2

As the medical team continues to manage the patient's condition, new diagnostic results provide further insight into his clinical status. The CT pulmonary angiogram confirms the presence of a small pulmonary embolism in the right lower lobe, correlating with the patient's persistent hypoxemia and increased respiratory rate. Additionally, the ultrasound of the right leg identifies a new deep vein thrombosis, explaining the severe leg pain and swelling. These findings underscore the critical nature of the patient's hypercoagulable state and the urgent need for effective anticoagulation.

In response to the confirmed thrombotic events, the team evaluates the patient's response to the argatroban infusion. Over the next 12 hours, the patient's oxygen saturation shows a slight improvement to 94% on 2 liters of supplemental oxygen via nasal cannula, and his respiratory rate stabilizes at 20 breaths per minute. However, his urine output remains low, with a total of 200 mL over the past 8 hours, and his creatinine level has risen slightly to 2.2 mg/dL, indicating ongoing concern for renal involvement. The nursing staff notes that the petechiae on the patient's lower extremities have not progressed, suggesting that the new anticoagulation regimen may be helping to stabilize the platelet activation.

Despite these positive signs, the team remains cautious, carefully monitoring for any further deterioration. They continue to assess the patient's hemodynamic status and prepare for potential escalation in care, should the patient exhibit signs of worsening renal function or respiratory compromise. The interdisciplinary team, including nephrology and pulmonology, is consulted to provide additional expertise in managing the complex interplay of thrombotic and bleeding risks in this vulnerable patient. As the unfolding clinical picture becomes clearer, the team is tasked with maintaining a delicate balance between addressing the thrombotic complications and preventing further decline in the patient's overall condition.

Section 3

As the medical team continues to monitor the veteran, a new complication arises. During routine vital signs assessment, the nursing staff observes that the patient's heart rate has increased to 110 beats per minute and his blood pressure has dropped to 88/56 mmHg, indicating possible hemodynamic instability. Concerned, they perform a focused assessment, revealing that the patient appears increasingly lethargic and is experiencing mild confusion. These findings prompt the team to consider the possibility of evolving complications, such as septic shock or further thrombotic events that might be exacerbating his condition.

In response to these changes, the medical team orders a series of diagnostic tests to better understand the underlying cause of the patient's declining status. Blood cultures are drawn to rule out infection as a source of sepsis, and a repeat CT scan of the chest is ordered to check for any new pulmonary emboli or progression of the existing one. Additionally, arterial blood gases are assessed, revealing a slight acidosis with a pH of 7.32 and a bicarbonate level of 18 mEq/L, suggesting metabolic acidosis, which could be linked to renal impairment or evolving shock state.

The patient's kidney function is closely scrutinized, given the previous rise in creatinine levels. New lab results indicate that creatinine has further increased to 2.5 mg/dL, and BUN is now 45 mg/dL. These values suggest worsening renal function, potentially due to poor perfusion or another underlying cause. The nephrology team recommends adjusting fluid management strategies to optimize renal perfusion while continuing to evaluate for signs of acute kidney injury. As the team synthesizes this information, the critical task is to stabilize the patient's hemodynamics and address the root cause of his condition to prevent further deterioration.

Section 4

The medical team decides to focus on the patient's hemodynamic instability, suspecting that his declining condition may be linked to both the heparin-induced thrombocytopenia (HIT) and potential septic shock. The heparin drip is immediately discontinued, and an alternative anticoagulant, argatroban, is initiated to manage the risk of thrombosis without exacerbating HIT. Despite these changes, the patient's heart rate remains elevated at 115 beats per minute, and his blood pressure persists at a low 90/58 mmHg, raising concerns about adequate tissue perfusion.

In light of the metabolic acidosis and worsening renal function, the nephrology team collaborates with the intensivists to adjust the patient's fluid management. They initiate a cautious fluid resuscitation protocol, administering isotonic saline to improve intravascular volume and support renal perfusion. Additionally, vasopressor support is considered to stabilize blood pressure, with norepinephrine being titrated to maintain a mean arterial pressure (MAP) above 65 mmHg. The team also closely monitors urine output, which has declined to 20 mL/hr, reinforcing the urgency in addressing potential acute kidney injury.

As these interventions are underway, new diagnostic results arrive. The blood cultures reveal a gram-negative bacteremia, confirming an infectious source contributing to the patient's septic state. This finding prompts the immediate initiation of broad-spectrum antibiotics, tailored to cover likely pathogens while awaiting sensitivity results. The team remains vigilant, aware that the combination of HIT, renal impairment, and sepsis requires a coordinated and dynamic approach to prevent further deterioration and stabilize the veteran's condition. As they await the patient's response to these interventions, the team prepares for potential escalation of care, including possible renal replacement therapy, to address any ongoing renal compromise.

Section 5

The veteran's condition continues to be closely monitored in the ICU as the medical team evaluates the response to the initiated interventions. Over the next several hours, the patient's vital signs show some signs of improvement. The heart rate gradually decreases to 102 beats per minute, and the blood pressure stabilizes slightly at 98/60 mmHg with the aid of norepinephrine. However, the mean arterial pressure hovers just above 65 mmHg, indicating that while there is some improvement, the patient remains hemodynamically fragile.

Despite the cautious fluid resuscitation efforts, the patient's urine output remains low at 25 mL/hr, suggesting persistent renal challenges. Laboratory tests reveal worsening metabolic acidosis, with a bicarbonate level dropping to 18 mEq/L and a rising blood urea nitrogen (BUN) level of 45 mg/dL, while the creatinine increases to 2.4 mg/dL. These findings, coupled with the gram-negative bacteremia, suggest a continued struggle against both the infectious process and compromised renal function. The nephrology team discusses the potential need for renal replacement therapy if the veteran's renal status does not improve with current interventions.

As the team works to manage the complex interplay of HIT, sepsis, and renal impairment, they remain vigilant for new complications. The evolving situation underscores the importance of dynamic clinical reasoning and the need to reassess and adjust the treatment plan continuously. The patient's response to antibiotics and the stabilization of his hemodynamic status are critical in determining the next steps in his care. The team prepares for a possible escalation of interventions, including the initiation of continuous renal replacement therapy, should the patient's renal function continue to decline.